Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Scrip Team

Advertisement
Set Alert for Articles By Scrip Team

Latest From Scrip Team

Executives On The Move: New Responsibilities For Sanofi CMO, A Strategic Promotion At Alexion And A C-Level Resignation At Medivir

To integrate digital and medical, Sanofi’s CMO Ameet Nathwani is now also Chief Digital Officer. Alexion promotes SVP to Chief Strategy and Business Development Officer, and the CFO resigns from Swedish oncology biotech Medivir.

Appointments BioPharmaceutical

Executives On The Move: C-Suite Exits At Pfizer, Celgene And Sandoz, New President At MorphoSys

C-suite moves at cancer biotech Geron Corp, EMD Serono Inc and Kiadis Pharma, while German biotech MorphoSys AG names David Trexler as its new president.

BioPharmaceutical Appointments

Executives On The Move: Clinical VPs Exit Eisai And Pfizer And New Top Hire At Histogen

Clinical VPs exit Eisai and Pfizer for positions at mRNA product firm CureVac and nanomedicines developer Taiwan Liposome. New chairman and CEO takes the reins at regenerative medicine company Histogen.

Appointments BioPharmaceutical

Executives On The Move: Research And Clinical Management Changes At Lundbeck, Sangamo And Angion

Research and clinical are in the spotlight this week with new EVP, R&D leaders at global CNS pharma Lundbeck and gene-based therapeutics firm Sangamo. And Angion Biomedica, a kidney disease biopharma, announces its new SVP, CMO.

Executives On The Move: Departures and Arrivals at Endologix, Gilead Sciences and Perrigo

Endologix CEO makes a switch to CEO at Vascular Therapies, and Clinical Research and Commercial VPs exit Gilead Sciences. Plus, producer of OTC and generic drugs Perrigo Company appoints EVP, CSO.

Appointments BioPharmaceutical

Executives On The Move: Science Leaders Exit Roche and Takeda

GI head departs Takeda for CMO spot at Ironwood Pharmaceuticals, and global head, oncology leaves Roche for CEO role at Tizona Therapeutics.

Appointments BioPharmaceutical
See All
Advertisement
UsernamePublicRestriction

Register